# Efficacy of the Vacucis Candida® Autovaccine

> **NCT05289375** · NA · NOT_YET_RECRUITING · sponsor: **University of Santiago de Compostela** · enrollment: 46 (estimated)

## Conditions studied

- Oral Candidiasis
- Oral Candidiasis Recurrent
- Radiotherapy; Complications
- Candida Albicans Infection
- Microbial Colonization
- Xerostomia

## Interventions

- **DRUG:** Vacucis autovaccine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05289375
- **Lead sponsor:** University of Santiago de Compostela
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-04-30
- **Primary completion:** 2026-04-30
- **Final completion:** 2027-12-31
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2024-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05289375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05289375, "Efficacy of the Vacucis Candida® Autovaccine". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05289375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*